1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321
Falling Comet
In 3 Starfolio Baskets
Download real time
883.75 -16.95 (-1.88%)
746.2K
NSE+BSE Volume

NSE 14 Jan, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Zydus Life’s US arm, Sentynl Therapeutics, gets US FDA nod for Zycubo to treat Menkes disease See details

Zydus Lifesciences - ZYDUSLIFE - stock price prediction, stock forecast, target price, analyst ratings from 30 analysts

Zydus Lifesciences has a share price target of Rs 1015, revenue growth forecast of 10.6%, and profit growth estimate of 2.8% for FY26, based on top 30 analyst calls.

Forecaster Screeners